PALM BEACH GARDENS, Fla., Feb. 9, 2012 /PRNewswire/ — Attitude Drinks (OTC.BB: ATTD) (OTCQB: ATTD), an innovative beverage brand development company and creator of the Phase III® Recovery brand, today announced a distribution agreement with Brown Distributing Company to service Phase III® throughout 269 Walgreens locations. Phase III® will be distributed by Brown in southeast Florida from Palm Beach County through Broward, Miami-Dade and Monroe counties to the Florida Keys.
AUSTIN, Texas, Feb. 9, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation (OTCBB: PSID), a developer of medical technologies for diabetes management, is now available. The interview can be heard at http://smallcapvoice.com/blog/2-8-12-smallcapvoice-interview-with-positiveid-corporation-otcbb-psid.
AUSTIN, Texas, Feb. 8, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with Viper Networks, Inc. (Pink Sheets: VPER) is now available. The interview can be heard at http://smallcapvoice.com/blog/2-6-12-smallcapvoice-interview-with-viper-networks-pink-sheets-vper
Independent Clinical Trial to Run for a Period of Six Months and Focus on People With Type 1 Diabetes
DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.
Independent Clinical Trial to Run for a Period of Six Months and Focus on People With Type 1 Diabetes
DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.
TAP wholly owned subsidiary signs contract to provide services to 1100+ outlets in China
HONG KONG, Feb. 6, 2012 /PRNewswire/ — Sino Payments, Inc. (OTCQB: SNPY) a technology Company providing proprietary IP transactions processing services to the retail industry, today announced that as a follow on to the recently announced merger with TAP Investments Group, a TAP wholly owned subsidiary in the People’s Republic of China (PRC) has signed a contract worth over USD1.5 Million with Wincor Nixdorf for the provision of Helpdesk, Hardware, Software Maintenance, New Store Opening and IMAC services to the world #1 Health & Beauty retailer’s 1100+ retail outlets in the PRC. The contract services started on the 1st of January 2012 and will last until 31stDecember 2012.